BioCentury
ARTICLE | Company News

Ibah, The Hardardt Group deal

October 7, 1996 7:00 AM UTC

IBAH signed a definitive agreement to purchase Hardardt, a CRO, for 2.7 million IBAH common shares and $14 million in cash. IBAH, which closed at $7.125 on Friday, had 18.7 million shares outstanding ...